Embedded protection for your molecule

Servier is a global pharmaceutical company that brings 60 years of expertise to its embedded CDMO business.

Servier CDMO - Embedded protection for your molecule
LATEST NEWS

Enhancing Responsiveness with Embedded Flexibility

by Gwenaël Servant

Pharma’s Almanac Q1 2017

In today’s pharmaceutical marketplace, speed to market is absolutely crucial. CDMOs with built-in flexibility are ideally situated to help drug companies shorten development and commercialization time lines. Flexibility can take many forms — from rapid tech transfer within an internal network to agile manufacturing configurations and use of automation, to the ability to rapidly respond to changing market and customer needs.

by Servier CDMO
Servier CDMO will be attending BIO International 2017 in San Diego, CA from 19th – 22nd June. We would welcome the opportunity to meet to learn about your business and discuss ways we may be able collaborate to advance your drug development and manufacturing goals. Contact us at cdmo@servier.com to schedule a meeting.
by Servier CDMO
Servier CDMO will be attending Chemspec Europe 2017 at the Munich Trade Fair Centre from 31st May – 1st June. We would love to give you a presentation of our services or to discuss your drug substance needs. Contact us to book a meeting.
by Servier CDMO

Servier CDMO has just launched our new website. You can now find out about our Products and Services and our expertise in the development and manufacturing of clinical to commercial drug substance and product. You can also view key information about services and key equipment at each of our manufacturing sites around the world. 

by Gwenaël Servant

Pharma’s Almanac Q1 2017

In today’s pharmaceutical marketplace, speed to market is absolutely crucial. CDMOs with built-in flexibility are ideally situated to help drug companies shorten development and commercialization time lines. Flexibility can take many forms — from rapid tech transfer within an internal network to agile manufacturing configurations and use of automation, to the ability to rapidly respond to changing market and customer needs.

by Phillipe Dartiguelongue

Preventing patient risk is perhaps the most important goal for any pharmaceutical manufacturer. The quality of a drug substance or product is directly linked to where and how it’s made. As a result of the gravity of production, management must ensure that process variation is eliminated, consistent quality is guaranteed and there are no threats of defects that may potentially harm patients or interrupt supply. To assure quality, Servier takes a holistic approach, bringing people, process and policy together to create an efficient, agile QA/QC culture. 

by Christian Sauveur

Pharmaceutical development is growing as the industry gains momentum in response to a broad range of market, regulatory and social trends globally. Advancing science, emerging markets and healthcare models are driving recent innovation and therapeutic success in the pharmaceutical sector, which has become increasingly dependent on partnerships across the supply chain. Collaboration is key to successfully responding to market demand – collaboration between both (bio)pharmaceutical companies and their service providers.

by Gwenaël Servant

Manufacturing Chemist – September 2016.

Accelerating successful drug development to meet global demand.

 

by Servier CDMO

Servier Tianjin Pharmaceutical Co. Ltd was registered in 2000. It is situated in the Tianjin Economic Technological Development Area, (TEDA) which is ranked as one of the top economic development zones in China. The site is located 45km from Tianjin and 120km from Beijing.

by Servier CDMO

Servier Brazil has been established for 40 years. We acquired a new industrial facility in 1995, located in Petropolis, about 75km from Rio de Janeiro. The Petropolis site produced sprays for the local market, repacking local production and QC analysis for imported product.

by Servier CDMO

Servier Egypt has two sites, situated a kilometer apart at Acacias and Palmiers, 50km from Cairo.

The Acacias site is dedicated to manufacturing activities — consisting of a complete granulation suite, four compression units and two coating pans — alongside Quality Control, Quality Assurance and IT. The Acacias site was built in 1994 and fully renovated in 2010.

by Servier CDMO

Servier has been present in Morocco since 1970 producing medicines for the Moroccan market initially under license. In 2002, Servier built a pharmaceutical manufacturing site dedicated to dry forms at the Nouasseur science park situated 25km from Casablanca.

by Servier CDMO

Toledo, Spain is located 70km from Madrid. Our Servier CDMO facility has 38 years of experience in fine chemistry, specializing in process development, analytical development and manufacturing. Our manufacturing processes us the most up to date production equipment and control techniques.

Why choose Servier CDMO

50
Products Launched
27
Billion Units Produced
60
Years of Experience
11
Facilities Worldwide
Learn how Servier can help you

Learn how Servier can help you

You want to protect your molecule – and there’s no better way than by engaging years of know-how, embedded quality, and understanding of your objectives. Servier brings these strengths to the integrated development, manufacturing, packaging and supply chain services for drug substance and drug product. We have 11 facilities worldwide and we have launched more than 50 commercial products. Your product can benefit from our experience and resources.

Global Network

Servier CDMO offers you the flexibility of 11 state-of-the-art manufacturing facilities worldwide. Servier has a presence in 148 countries.

Contact

Experience 60 years of embedded quality, know-how and reliability when you work with Servier CDMO. Contact us to discuss our service offering and your project needs.